ArticlePharmaceutics2021

Physicochemical Characterization of a Co-Amorphous Atorvastatin-Irbesartan System with a Potential Application in Fixed-Dose Combination Therapy.

Marcin Skotnicki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.